ASX:MSB

Mesoblast Ltd - MSB share price

$ - -

About Mesoblast Ltd

Mesoblast Limited, an Australian-based company, focuses on developing late-stage product candidates using proprietary mesenchymal lineage cell therapy platforms. Their flagship products, Remestemcel-L and Rexlemestrocel-L, are in late-stage development for treating various systemic inflammatory diseases and chronic conditions such as acute Graft versus Host Disease, respiratory distress syndrome, chronic heart failure, and low back pain due to degenerative disc disease. Additionally, Mesoblast has commercialized two products in Japan and Europe and established partnerships for Phase III assets in Europe and China.

Company Profile

Market Cap -

Book Value -

Enterprise Value -

Revenue TTM -

Shares Outstanding -

Earning Share

Shares Float -

Dividend per Share

P/E Ratio -

Div Yield -

Disclaimer: The above financial data is sourced from EODHD and is for informational purposes only. Veye does not guarantee the accuracy or completeness of this data. Investors should conduct their own research and consult with a financial advisor before making investment decisions.

Price Summary

Today's Low Today's High

- -

52 Week High

52 Week Low

Price Chart (MSB)

TOP ASX STOCKS Worth Watching

✓ Instant Access
✓ No Credit Card Required
✓ Free to join · No spam

Get Free Report on WhatsApp

Free to join · No spam · Unsubscribe anytime

Special Research Report

Discover the Top ASX Stocks to Invest in 2026!

Expert Analysis of Top-Performing ASX Stocks

Market Insights and In-Depth Research

Buy, Sell, And Hold Recommendations

Almost There!

Enter your details to download the report

Full Name

Email Address

Phone Number

By providing your details, you agree to Veye’s Terms & Conditions, Privacy Policy, and Financial Services Guide and to receive marketing offers by email, text message or phone call from us or our agents until you opt out. Before you access our services, please read the Financial Service Guide available here.